Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S. By: CNBC.com News July 02, 2024 at 14:04 PM EDT It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial rejection from the FDA last year. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S. By: CNBC.com News July 02, 2024 at 14:04 PM EDT It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial rejection from the FDA last year. Read More >>